Wait a few moments, please...  Wait a few moments, please...
    
Metadata (Opens new window)Get table previously savedSave tableDownload Chart (JPEG, PNG or PDF format)Conventional signs (Opens new window)

Place of residence (NUTS II - 1999) (1) Vaccination coverage to individuals who complete 2 years of age (2017 - %) by Place of residence (NUTS II - 1999) and Type of administrated vaccine; Annual (3)
Data reference period (2)
2021
Type of administrated vaccine
Hib4: Vaccine against invasive disease caused by Haemophilus influenzae (4th inoculations)MenC: Vaccine against invasive disease caused by Neisseria meningitidis C (single dose)Pn133: Conjugate vaccine against infections by Streptococcus pneumoniae of 13 serotypes (3rd inoculations)Dif4: Vaccine against diphteria (4th inoculations)Tet4: Vaccine against tetanus (4th inoculations)Tcp4: Vaccine against whooping cough/pertussis (4th inoculations)Sar1: Vaccine agains measles (1st inoculations)Par1: Vaccine against mumps (1st inoculations)Rub1: Vaccine against rubella (1st inoculations)VIP4: Injectable inactivated vaccine against polio (4th inoculations)MenB3: Vaccine against invasive disease caused by Neisseria meningitidis B (3rd inoculations)
% % % % % % % % % % %
PT: Portugal96,598,398,096,596,596,598,498,498,496,588,9
1: Continente96,598,397,996,596,596,598,498,498,496,588,8
2: Região Autónoma dos Açores97,897,998,897,897,897,899,099,099,097,884,6
3: Região Autónoma da Madeira97,599,299,197,597,597,599,599,599,597,593,9
Vaccination coverage to individuals who complete 2 years of age (2017 - %) by Place of residence (NUTS II - 1999) and Type of administrated vaccine; Annual - Directorate-General of Health
Note(s):
(1) From 2017 onwards, vaccine coverage will be made available by vaccine against a disease, not by monovalent or combined vaccine;
(2) These values are in accordance with the recommended scheme.
(3) Since 2016, BCG vaccine is recommended only for at-risk groups.

This data last updated:march 03, 2023